Daly James M Insider Trades

Insider Trading History

Track insider trading activity for Daly James M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $0 0 shares
Last Trade
May 29, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$176k 8,107 shares
$21.66
$22.60
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $275k 12,148 shares
Last Trade
May 29, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$176k 8,107 shares
$21.66
$22.60
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $362k 16,004 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$548k 25,315 shares
$21.66
$22.60
Cytokinetics
Cytokinetics CYTK
Director
Holding Value $344k 4,301 shares
Last Trade
May 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$552k 7,152 shares
$77.15
$80.01
Cytokinetics
Cytokinetics CYTK
Director
Holding Value $31k 388 shares
Last Trade
Apr 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.5k 191 shares
$65.37
$80.01
Cytokinetics
Cytokinetics CYTK
Director
Holding Value $15.8k 197 shares
Last Trade
Jan 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.5k 197 shares
$63.44
$80.01
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $91.3k 4,041 shares
Last Trade
Nov 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$671k 30,000 shares
$22.37
$22.60
Cytokinetics
Cytokinetics CYTK
Director
Holding Value $2.2M 27,450 shares
Last Trade
Aug 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.04M 27,450 shares
$37.84
$80.01
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Director
Holding Value $1.35M 2,627 shares
Last Trade
Jun 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$573k 2,005 shares
$285.73
$513.43
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $769k 34,041 shares
Last Trade
May 29, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$209k 9,387 shares
$22.29
$22.60
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $0 0 shares
Last Trade
May 29, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$209k 9,387 shares
$22.29
$22.60
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $312k 13,793 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$307k 13,793 shares
$22.29
$22.60
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Director
Holding Value $8.92M 17,382 shares
Last Trade
Feb 27, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.19M 15,470 shares
$335.74
$513.43
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Director
Holding Value $0 0 shares
Last Trade
Feb 27, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.19M 15,470 shares
$335.74
$513.43
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Director
Holding Value $8.72M 16,984 shares
Last Trade
Feb 27, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.38M 15,470 shares
$347.45
$513.43
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Director
Holding Value $982k 1,912 shares
Last Trade
Jun 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$309k 1,105 shares
$280.04
$513.43
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $0 0 shares
Last Trade
May 29, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$97.3k 6,652 shares
$14.62
$22.60
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $557k 24,654 shares
Last Trade
May 29, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$97.3k 6,652 shares
$14.62
$22.60
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $361k 15,959 shares
Last Trade
May 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$233k 15,959 shares
$14.62
$22.60
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Director
Holding Value $0 0 shares
Last Trade
Apr 02, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.67M 10,912 shares
$244.50
$513.43

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up